XML 46 R37.htm IDEA: XBRL DOCUMENT v3.23.2
MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Sanofi S.A. (Details)
 1 Months Ended 3 Months Ended 6 Months Ended 102 Months Ended
Sep. 06, 2022
USD ($)
Jan. 31, 2014
USD ($)
program
Jun. 30, 2023
USD ($)
Jun. 30, 2022
USD ($)
Jun. 30, 2023
USD ($)
product
milestone
Jun. 30, 2022
USD ($)
Jun. 28, 2022
USD ($)
Dec. 31, 2022
USD ($)
Research and Development Arrangement, Contract to Perform for Others [Line Items]                
Revenues     $ 6,835,000 $ 29,378,000 $ 164,792,000 $ 57,609,000    
Accounts receivable     2,716,000   2,716,000     $ 3,678,000
Prepaid Expenses and Other Current Assets                
Research and Development Arrangement, Contract to Perform for Others [Line Items]                
Decrease in research and development expense     700,000   1,300,000      
Sanofi S.A.                
Research and Development Arrangement, Contract to Perform for Others [Line Items]                
Number of research programs | program   2            
Revenues under agreement   $ 20,000,000            
Revenues     0 $ 1,800,000 $ 0 $ 3,300,000 $ 13,500,000  
Number of products approved | product         0      
Expenses reimbursable through December 31, 2023 (up to) $ 7,000,000              
Expenses reimbursable after December 31, 2023 (up to) $ 5,300,000              
Sanofi S.A. | Collaboration And License Agreement                
Research and Development Arrangement, Contract to Perform for Others [Line Items]                
Revenues under agreement             20,000,000  
Number of milestones included in transaction price | milestone         0      
Collaborative arrangement transaction price             96,300,000  
Collaborative arrangement estimated reimbursable service costs             62,800,000  
Accounts receivable     0   $ 0     0
Contract with customer liability     $ 0   $ 0     $ 0
Sanofi S.A. | Collaboration And License Agreement | Milestone Three                
Research and Development Arrangement, Contract to Perform for Others [Line Items]                
Milestone revenue receivable             $ 13,500,000